These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 131782)

  • 1. Characterization of a T-lymphocyte inhibitor in the serum of tumour-bearing mice.
    Levy JG; Smith AG; Whitney RB; McMaster R; Kilburn DG
    Immunology; 1976 Apr; 30(4):565-73. PubMed ID: 131782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identity of a T-lymphocyte inhibitor with mouse immunoglobulin in the serum of tumour-bearing mice.
    Levy JG; McMaster R; Kelly B; Whitney RB; Kilburn DG
    Immunology; 1977 Apr; 32(4):475-81. PubMed ID: 305409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
    Whitney RB; Levy JG
    J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression of T lymphocyte function by fractionated serum from tumor-bearing mice.
    McMaster R; Buhler K; Whitney R; Levy JG
    J Immunol; 1977 Jan; 118(1):218-22. PubMed ID: 299757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-mediated suppression of nonspecific B cell activation. I. Description of an inhibitory capacity in normal mouse serum and characterization of the inhibitory component.
    Walker SM; Sturtevant JE; Weigle WO
    J Immunol; 1981 May; 126(5):1852-56. PubMed ID: 6163819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
    Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of concanavalin A on the in vitro responses of mouse spleen cells to T-dependent and T-independent antigens.
    Jacobs DM
    J Immunol; 1975 Jan; 114(1 Pt 2):365-70. PubMed ID: 1090654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
    J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses.
    Ishizaka K; Adachi T
    J Immunol; 1976 Jul; 117(1):40-7. PubMed ID: 1084370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-specific inhibitory processes of immunological and mitogenic cellular responses.
    Liacopoulos M; Lambert F; Liacopoulos P
    Immunology; 1980 Sep; 41(1):143-52. PubMed ID: 6448806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism between immune complexes and serum from tumor-bearing mice in the suppression of mitogen responses.
    Kilburn DG; Fairhurst M; Levy JG; Whitney RB
    J Immunol; 1976 Nov; 117(5 Pt 1):1612-7. PubMed ID: 1002993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
    Maier T; Holda JH
    J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
    McMaster R; Levy JG
    J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.
    Raskova J; Morrison AB; Shea SM; Raska K
    Am J Pathol; 1979 Nov; 97(2):277-90. PubMed ID: 230740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of radiolabeled alloantibodies in mice bearing 3-methylcholanthrene-induced sarcoma.
    Buchsbaum DJ; Walker PC; Johnson EA
    Cancer Res; 1979 Sep; 39(9):3363-8. PubMed ID: 476667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression of T lymphocyte function by fractionated serum from tumor-bearing mice.
    McMaster R; Buhler K; Whitney R; Levy JG
    J Immunol; 1977 Jan; 118(1):223-5. PubMed ID: 830748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular basis of in vitro anti-DNA antibody production: evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB X NZW)F1 hybrid.
    Sekigawa I; Ishida Y; Hirose S; Sato H; Shirai T
    J Immunol; 1986 Feb; 136(4):1247-52. PubMed ID: 3484766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.